Assessing subject diversity by condition and trial phase in clinical trials

被引：1
|
作者：
Gorrepati, Pavane L. [1 ]
Smith, Gideon P. [1 ]
机构：
[1] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2023年 / 62卷 / 02期
关键词：
D O I：
10.1111/ijd.16043
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E65 / E67
页数：3
相关论文
共 50 条
  • [31] A tool for assessing adverse events in phase I/II oncology clinical trials
    Coombes, M.
    Mukherjee, S.
    Kowaleski, B.
    Levine, M.
    Cosby, J.
    Arnold, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [32] The pragmatic clinical trial - an attempt to overcome shortcomings of phase II/III clinical trials
    Kahn, RS
    EUROPEAN PSYCHIATRY, 2004, 19 : 61S - 61S
  • [33] A round-up of clinical trial reports - Phase III trials
    不详
    BIOTECHNOLOGY LAW REPORT, 2002, 21 (04) : 345 - 351
  • [34] A round-up of clinical trial reports - Phase III trials
    不详
    BIOTECHNOLOGY LAW REPORT, 2001, 20 (04) : 562 - 570
  • [35] Clinical trial design in phase 2 and 3 trials for pulmonary hypertension
    Nikkho, Sylvia
    Fernandes, Peter
    White, R. James
    Deng, Chunqin
    Farber, Harrison W.
    Corris, Paul A.
    PULMONARY CIRCULATION, 2020, 10 (04)
  • [36] Assessing the success probability of a Phase III clinical trial based on Phase II data
    Su, Zheng
    CONTEMPORARY CLINICAL TRIALS, 2010, 31 (06) : 620 - 623
  • [37] Assessing Longitudinal Medication Use in Pragmatic Clinical Trials: Insights From the ARTEMIS Trial
    Wang, Tracy
    Kaltenbach, Lisa A.
    Fonarow, Gregg C.
    Henry, Timothy D.
    Cannon, Christopher P.
    Cohen, David J.
    Fonseca, Eileen
    Bhandary, Durgesh D.
    Khan, Naeem
    Anstrom, Kevin J.
    Peterson, Eric D.
    CIRCULATION, 2017, 136
  • [38] Diversity, equity, and inclusion in clinical trials: A practical guide from the perspective of a trial sponsor
    Versavel, Stacey
    Subasinghe, Alicia
    Johnson, Kenasha
    Golonski, Nicole
    Muhlhausen, Janna
    Perry, Pamela
    Sanchez, Raymond
    CONTEMPORARY CLINICAL TRIALS, 2023, 126
  • [39] Quantifying Clinical Trial Diversity in Pivotal Registration Trials of FDA Novel Drug Approvals
    Muhammed Y. Idris
    William E. Fitzsimmons
    Priscilla Pemu
    Therapeutic Innovation & Regulatory Science, 2024, 58 : 175 - 183
  • [40] Quantifying Clinical Trial Diversity in Pivotal Registration Trials of FDA Novel Drug Approvals
    Idris, Muhammed Y.
    Fitzsimmons, William E.
    Pemu, Priscilla
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (01) : 175 - 183
12345